Search

La nueva unidad de salud móvil de MSK ofrece servicios de educación para la salud, pruebas de detección y orientación a comunidades marginadas del área metropolitana de Nueva York.

… Thursday, April 6, 2023 Mobile Health Unit MSK’s Mobile Health Unit parked at St. Michael’s Church in Sunset Park, Brooklyn, on January 21, 2022 Ramon Gonzalez Mobile Health Unit driver Ramon Gonzalez with informational flyers for community members passing the church. Jessica Llamozas MSK nurse Jessica

Most people are aware of how important clinical trials for cancer are and how they can lead to lifesaving breakthroughs, but they’re also unlikely to participate in them.

… Monday, May 23, 2016 Summary Nearly every cancer treatment available today exists because of a clinical trial. Despite their importance, people don’t know much about cancer clinical trials and are also unlikely to enroll in them. Once they learn more, though, patients are far more likely to participate

Nearly 400 adults and children have received umbilical cord blood transplants at MSK. These transplants offer the best chance of a cure for blood cancer in patients who are unable to find a matched donor, often due to their non-European ancestry.

… Thursday, September 15, 2022 For some people with blood cancer, getting a stem cell or bone marrow transplant from a donor offers the best chance of a cure. It’s called an allogeneic transplant . But finding a donor who’s the right match can be difficult for many people — especially those of southern

Casi 400 adultos y niños han recibido trasplantes de sangre del cordón umbilical en MSK. Estos trasplantes ofrecen la mejor posibilidad de cura para el cáncer de sangre en pacientes que no pueden encontrar un donante compatible, a menudo debido a su ascendencia no europea.

… Thursday, September 15, 2022 Para algunas personas con cáncer de sangre, recibir un trasplante de células madre o de médula ósea de un donante ofrece la mejor posibilidad de curación. Se llama trasplante alogénico . Pero encontrar un donante que sea compatible puede ser difícil para muchas personas,

Learn why surgery is still a good option for older patients with early-stage lung cancer.

… Wednesday, November 2, 2016 Summary Older patients are sometimes reluctant to have surgery for lung cancer because they mistakenly believe the risk outweighs the benefits. A new study shows that older patients who receive surgery at MSK usually survive their lung cancer for more than five years and are

New MSK research investigates harnessing the power of ferroptosis to spread cell death; reports how an MSK artificial intelligence (AI) model could help improve patient safety; and uses AI to reveal country-specific drivers of global cancer outcomes.

… Monday, February 23, 2026   New research from Memorial Sloan Kettering Cancer Center (MSK) investigates harnessing the power of ferroptosis to spread cell death; reports how an MSK artificial intelligence (AI) model could help improve patient safety; and uses AI to reveal country-specific drivers of

MSK researchers have developed a new open-source computational method, dubbed Spectra, which improves the analysis of single-cell transcriptomic data — and made it freely available to researchers around the world.

… Thursday, October 5, 2023 Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed a new open-source computational method, dubbed Spectra, which improves the analysis of single-cell transcriptomic data. By guiding data analysis in a unique way, Spectra can offer new insights into the

The high-resolution views provided by cryo-electron microscopy are helping scientists learn how proteins and DNA collaborate to repair broken DNA.

… Tuesday, December 1, 2020 Summary Using cryo-electron microscopy, researchers at the Sloan Kettering Institute have gained an important insight into how cells repair broken DNA, a process fundamental to life that sometimes goes awry in cancer. A landmark in cancer research was the discovery, in the early

Dr. Craig Thompson, Dr. Peter Bach, Dr. Ushma Neill, and Dr. William Rosa were recognized for their professional, civic, and philanthropic achievements.

… Monday, July 12, 2021 Memorial Sloan Kettering is proud to announce that President & Chief Executive Officer Craig B. Thompson, MD , Director of the Center for Health Policy and Outcomes Peter B. Bach, MD, Vice President of Scientific Education & Training Ushma Neill, PhD , and Postdoctoral Research

The May 13 installment of “MSK Science Spotlight” will feature co-winner of The Society of Memorial Sloan Kettering Prize, Carl June, MD.

… Wednesday, May 13, 2020 The May 13 installment of “MSK Science Spotlight” will feature co-winner of The Society of Memorial Sloan Kettering Prize, Carl June, MD. Dr. June is Director of the Center for Cellular Immunotherapies and Professor, Department of Pathology and Laboratory Medicine, Perelman School